FullHope Biomedical Co.,Ltd. (TPEX:7773)
31.15
+0.65 (2.13%)
At close: Feb 11, 2026
FullHope Biomedical Company Description
FullHope Biomedical Co.,Ltd. engages in the research and development of immune system-related services.
It develops FHCT001 and FHCT003, an immune cell therapies for cancer; and FHCT002, an auto-immune cell therapy, as well as diagnostic tools.
The company also provides various services, including immunoprofiling, circulating tumor cells testing, regulation of cell therapy, contracting immune cell manufacturing, immune cell bank, contract research organization, and endotoxin and mycoplasma detection.
FullHope Biomedical Co.,Ltd. was founded in 2012 and is based in New Taipei City, Taiwan.
FullHope Biomedical Co.,Ltd.
| Country | Taiwan |
| Founded | 2012 |
| Industry | Biological Products, Except Diagnostic Substances |
Contact Details
Address: No. 10, Ln. 609 New Taipei City, 24159 Taiwan | |
| Phone | 886 2 2995 3838 |
| Website | fhb.com.tw |
Stock Details
| Ticker Symbol | 7773 |
| Exchange | Taipei Exchange |
| Stock Type | Common Stock |
| Reporting Currency | TWD |
| SIC Code | 2836 |